Bliss GVS Phrma

BSE : 506197 | NSE : BLISSGVS

Industry : Pharma Formulations | ISIN : INE416D01022 | FreeFloat : 40.00% | FnO : No | LotSize : N/A


Intellectual Capital (IC)110.74
Net Worth (NW)875.98
Intrinsic Worth (IW)986.73
Market Cap (MC)1,137.05
Economic Value Added-4.29
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)11.22%
IC Gross Margin (EBITDA/IC)115.80%
IC Net Margin (NPT/IC)66.21%
Knowledge Turnover (Sales/IC)5.00
Market to Intrinsic Value (MC/IW)1.15

As OfIntrinsic ValueMarket Price
30 Sep 2021Rs. 95.33Rs. 109.85
6 Dec 2021 ---- Rs. 100.00
-0.95     -0.95%
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : NoSell10 DMA : Rs. 99.58ReduceSell
KB > 50% : No50 DMA : Rs. 105.97
0 < M2IV < 1 : NoVol-Price trend : Falling

Question 3 - Is this stock undervalued?


Question 2 - Does this business have significant knowledge assets?


Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.

Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Dec-18
C
220.43
216.53
39.64
37.44
36.48
27.23
24.13
Mar-19
C
244.05
246.84
34.73
32.52
31.60
18.79
18.88
Jun-19
C
211.53
213.64
51.07
48.30
47.41
33.37
34.06
Sep-19
C
210.12
223.02
38.36
34.87
33.81
30.86
34.05
Dec-19
C
147.85
153.37
38.46
35.49
34.41
25.45
22.88
Mar-20
C
119.90
136.40
19.07
15.72
13.33
5.57
7.94
Jun-20
C
129.55
136.59
26.52
22.23
20.40
16.65
16.96
Sep-20
C
151.54
154.28
34.74
30.43
30.05
21.61
18.61
Dec-20
C
164.06
168.18
42.39
38.03
37.09
27.56
25.86
Mar-21
C
132.05
138.38
23.21
18.94
16.58
8.15
11.17
Jun-21
C
168.15
175.96
42.42
38.08
36.69
26.13
25.31
Sep-21
C
195.99
201.44
34.86
30.56
29.89
22.06
22.29
* C - Consolidated, S - Standalone